The world’s top cannabis industry leaders will convene in an unprecedented gathering in Davos, Switzerland from January 22-25.
Ehud Barak, former Israeli Prime Minister and Chairman of InterCure, Roei Zerahia CEO CANNDOC, Yona Levy CEO of Alvit and Tefen, Eyal Barad CEO Cannabics, Lorne Gertner Chairman of Hiku Brands, Jason Warnock CEO of TheraCann and Saul Kaye CEO of iCAN: Israel Cannabis are just some of the industry leaders that will participate at the CannaTech Pavilion events in Davos.
“I am thrilled that CannaTech will be co-hosting the Canada Cannabis House along with the Canadian Securities Exchange (CSE), OTC markets, and Kapoor Capital in Davos. CannaTech has been widely claimed as the “Davos” of Cannabis conferences and it is an honor to participate there and help regulators and industry giants understand the impact of this emerging industry on a global level. The burgeoning cannabis industry is poised to revolutionize patient care and the leisure industry and these changes are creating new international ecosystems that will have massive impact, from local farm workers to the world’s largest corporations. Cannabis is part and parcel of the next wave of globalization and a serious discussion in Davos could not be more timely,” said iCAN’s Saul Kaye.
Schedule of Events:
Tuesday Jan 22nd 4-6:00 pm
Cannabis in the Capital Markets – What’s Getting Funded Next?
USA vs. Canada
Vik Kapoor & Saul Kaye
Richard Carleton (CSE), Jason Paltrowitz (OTC), and Dan Daviau (Canaccord); Moderated by James Black (CSE)
Bruce Linton (Canopy), Kevin Murphy (Acreage)
Wednesday Jan 23rd 3:00-5:00 pm
The Next Investment Opportunities in Global Cannabis Expansion
How to Build International Brands in the Cannabis Industry
Lorne Gertner (Hiku)
Prakash Hariharan (Radient), Boris Blatnik (KannaSwiss), Antonio Costanzo (EMMAC); Moderated by
Paul Sparkes (Invictus), Mike Dacks (Plena); Moderated by Mark Goldhar (Civilized)
Thursday Jan 24th 3:30-6:00 pm
An interview with Ehud Barak
10th Prime Minister of Israel
Ehud Barak interviewed by Anthony Scaramucci
Emerging Markets – Asia & LATAM
Philip Gu (SCU/Casnnacubed), Stuart Bobrow (Cannahub); Moderated by Raymond D. Harari (Canalis Capital)
Exporting Cannabis Innovation to the World
Cannabis 2020 and beyond
Yona Levy (Alvit Israel), Roei Zerahia (CANNDOC Israel), Jason Warnock (TheraCann), Eyal Barad (Cannabics Israel)
Antonio Costanzo (EMMAC)
Joining iCAN in Davos will be leading Israeli and global cannabis companies: Theracann, CANNDOC, Alvit, Plena, Cannabics, Cannacubed and Cannahub. For Sponsorships opportunities at the CannaTech Canada Cannabis House contact Joshua@israel-cannabis.com.
CannaTech is the only Medical Cannabis event of its kind with a global focus that offers senior industry leaders, medical and scientific experts, and new ventures the platform to come together, drive innovation, form partnerships and promote knowledge exchange.
About iCAN: Israel-Cannabis
iCAN: Israel-Cannabis is building the Global Cannabis Ecosystem. iCAN is committed to accelerate Israel’s Canna-Technology industry, capitalizing on Israeli innovation and a leading cannabis regulatory environment to bring premier products to market. iCAN is powered by CannaTech, the premier international cannabis summit held annually in Tel Aviv, and around the world including London, Sydney, Hong Kong and now Panama in February, 2019.
Alvit LCS Pharma was founded in 2014 with the goal of researching and developing cannabis-based pharmaceutical products that speak the language of doctors. Since then, the company has successfully developed a broad line of pharma grade cannabis products that include various types of tablets, sprays, suppositories, and more. Several of these products have already completed or been approved for clinical trials in Israel.
Alvit is a vertically integrated company which controls the entire life cycle of the cannabis drug development process, including GAP (Good Agriculture Practice) controlled cultivation of proprietary cannabis clones, standardized extracts, preclinical evaluations, proprietary formulations, and first-in-human studies.
Cannabics Pharmaceuticals Inc. (CNBX) is a U.S public company that is developing a platform which leverages novel drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer that are more precise to a patient’s profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The company’s R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and Cancer.
InterCure (CANDOCC Pharma) is the first and only public company on the Tel Aviv Stock Exchange (TASE: INCR), which holds a valid and permanent license for the entire medical cannabis value chain. The company has recently acquired full ownership and control (100%) of CANNDOC Pharma, a leading pioneer in the medical cannabis sector in Israel and worldwide, and has been in engaged in ten years of research, nurturing, cultivating and marketing medical cannabis to thousands of patients with a range of indications that have been approved by Israel’s Ministry of Health and collaborate with partners in Israel and abroad. Visit https://www.canndoc.co.il
Plena Global Holdings Inc. is a medical cannabis production company meeting the soaring demands of a rapidly expanding global marketplace with cGMP grade medical cannabis products and assets. Based in Canada, the Plena team has broad experience in the industry and brings together some of the world’s top cannabis horticulturists, extraction specialists, and medical leaders. Driven by a passion for helping people in need, Plena brings medical cannabis from plant to patient-naturally, purely, reliably and transparently. With expansive farmland assets dedicated to medical cannabis growth, Plena has positioned itself to be the world’s largest producer of cGMP medical-grade cannabis, all while adhering to the strictest quality standards. Plena is a strong ingredient supply partner for licensed producers and distributors worldwide.
About Stem Cell United (SCU) (Cannacubed)
Stemcell United Limited (ASX:SCU) is an Australian mainboard listed biotechnology company which focuses on using plant stem cell technology for the valued plant genome mapping, authentication, cell and molecule breeding, cultivation, extraction, culture, reproduction, and usage of plant based Traditional Medicine for medicinal health and beauty applications. SCU’s current medicinal, anti-aging and beauty products are derived from the stem cell essence of
Daemonorops Draco Blume, Dendrobium Officinale and Cannabis Sativa SCU has got China’s hemp licence permitting SCU to breed, plant, process, distribute and import/export hemp related products. The licence would also allow SCU to access high CBD low THC cannabis seeds which SCU can use for its stem cell cannabis research into TCM beauty products. Leveraging on SCU’s expertise in plant biotechnologies and experience in Asia, SCU will, together with Cannacubed and CHIC Group, build the world largest diversified eco-hemp health park which will grow its special high CBD cultivars to produces hundreds of tonnes of CBD oil per year, and with Tencent Group a Global Hemp Data Centre in the park.
Founded in 2004, TheraCann International Benchmark Corporation offers a one-stop, full-service solution for the International cannabis marketplace. TheraCann provides business, technology and industry experts who apply advanced technology and help clients design, build and run their cannabis businesses. Integrating nearly 3.5 million square feet of cannabis operations and the successful launch of groundbreaking Enterprise Resource Planning (ERP) software, Aeroponic cultivation systems and patented genetic tracking and diversion prevention systems, TheraCann provides cannabis-related businesses with solutions to fit their regulatory requirements. More information about TheraCann is available at http://www.theracanncorp.com